Worldwide, approximately 50 million people suffer from epilepsy [1]. Although most patients benefit from treatment with anti-epileptic drugs (AEDs), a minority of patients does not respond to AEDs even with adequate dosage in either mono- or polytherapy [2].
9
JUN
JUN
0